Trial Profile

Nocturnal Hypertension and Prevention of Microalbuminuria in Type 1 Diabetes

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ramipril (Primary)
Indications Proteinuria
Focus Therapeutic Use
Acronyms PREVENTKD

Most Recent Events

17 Mar 2015 Biomarkers information updated
02 Jun 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
29 Oct 2008 Additional trial identifier 1U01DK071733-01A1 added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com